Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11767520 Compositions and methods for treating lung inflammation

Patent 11767520 was granted and assigned to aTyr Pharma on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
aTyr Pharma
aTyr Pharma
Date Filed
April 19, 2018
Date of Patent
September 26, 2023
Patent Applicant
aTyr Pharma
aTyr Pharma
Patent Application Number
16499979
Patent Citations
‌
US Patent 7459529 AIMP2-DX2 and its uses
‌
US Patent 7476651 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
‌
US Patent 7482326 Endothelial-monocyte activating polypeptide III
‌
US Patent 7521215 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
‌
US Patent 7528106 Compositions and methods for treatment of neovascular diseases
‌
US Patent 7572452 Method for stimulating wound healing
‌
US Patent 7745391 Human thrombospondin polypeptide
‌
US Patent 7842467 Breast disease targets and uses thereof
‌
US Patent 7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
‌
US Patent 7902165 Use of AIM3 acting as a tumor suppressor
•••
Patent Inventor Names
Kathleen Ogilvie
John D. Mendlein
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11767520
Patent Primary Examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 11767520 Compositions and methods for treating lung inflammation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.